跳至主要内容
临床试验/NCT04256824
NCT04256824招募中4 期

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study

ClinAmygate1 个研究点 分布在 1 个国家目标入组 430 人开始时间: 2020年2月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
430
试验地点
1
主要终点
Incidence of surgical site infection

研究概览

简要总结

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

详细描述

Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age: 18-75
  • clean-contaminated wound surgery

排除标准

  • Patient has immunodeficiency disorder.
  • Patient receiving anti-cancer / immunosuppressive therapy.
  • Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.

研究组 & 干预措施

Coated Polyglactin 910 with Triclosan

Experimental

Coated vicryl plus

干预措施: coated vicryl plus (Drug)

Coated Polyglactin 910 without Triclosan

Active Comparator

Coated vicryl

干预措施: Vicryl (Drug)

结局指标

主要结局

Incidence of surgical site infection

时间窗: 30 days

Incidence of surgical site infection within 30 days

次要结局

  • Hospital stay(30 days)

研究者

发起方
ClinAmygate
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验